374822-48-7 Usage
Uses
Used in Oil and Gas Industry:
C6H13NO is used as a corrosion inhibitor for protecting metal surfaces and equipment from corrosion, which is crucial in maintaining the integrity and longevity of oil and gas infrastructure.
Used in Cleaning Products:
In the cleaning industry, C6H13NO serves as a surfactant, enhancing the effectiveness of cleaning products by reducing surface tension and improving the solubility of dirt and grease.
Used in Pharmaceutical Industry:
C6H13NO is also utilized as a compound in certain pharmaceuticals, leveraging its unique chemical properties to contribute to the development of new medications and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 374822-48-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,7,4,8,2 and 2 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 374822-48:
(8*3)+(7*7)+(6*4)+(5*8)+(4*2)+(3*2)+(2*4)+(1*8)=167
167 % 10 = 7
So 374822-48-7 is a valid CAS Registry Number.
374822-48-7Relevant articles and documents
Synthesis of key intermediate for (+)-tofacitinib through CoIII(salen)-catalyzed two stereocentered hydrolytic kinetic resolution of (±)-methyl-3-(oxiran-2-yl)butanoate
Kamble, Rohit B.,Suryavanshi, Gurunath
, p. 1045 - 1051 (2018/03/23)
An enantiopure piperidine, a key intermediate for the synthesis of (+)-tofacitinib, has been achieved in high optical purity (98% ee) from readily available crotyl alcohol. The key steps involved is a CoIII(salen)-OAc-catalyzed two stereocentered hydrolytic kinetic resolution of (±)-methyl-3-(oxiran-2-yl)butanoate.
NOVEL HETEROCYCLYL COMPOUNDS
-
Page/Page column 20-21, (2010/02/17)
The invention is concerned with novel heterocyclyl compounds of formula (I) wherein A, X, Y1, Y2, Y3, R3, R4, R5, R6, R7, R8, R9, R10, m, n and p are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.
